{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:36:18Z","timestamp":1793799378380,"version":"4.6.1"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Several studies have explored the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on bone mineral density (BMD) and bone turnover markers (BTMs) in adults and the risk of osteoporotic fractures. However, the extent of adverse effects of MASLD on bone health remains uncertain. This systematic review and meta-analysis aimed to investigate the effects of MASLD on bone health in adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Medline, EMBASE, Cochrane Library, and Scopus for observational studies published from inception to June 2025 that reported MASLD effects on bone health.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This meta-analysis indicated that MASLD was associated with increased femur BMD (WMD: 0.03 g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      , 95% CI: 0.02 to 0.03, P&amp;lt;0.001), especially in women (WMD: 0.02 g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      , 95% CI: 0.01 to 0.04, P = 0.002) and overweight people (WMD: 0.04 g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      , 95% CI: 0.01 to 0.06, P = 0.002). MASLD was also significantly associated with increased osteoporosis\/osteoporotic fractures (OR: 1.23, 95% CI: 1.13-1.34; P&amp;lt;0.001) and decreased BTMs (CTX: WMD: -0.03 ng\/mL, 95% CI: -0.05 to -0.02, P&amp;lt;0.001; OC: WMD: -1.86 ng\/mL, 95% CI: -2.69 to -1.03, P&amp;lt;0.001; P1NP: WMD: -4.59 ng\/mL, 95% CI: -5.64 to -3.54, P&amp;lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MASLD was significantly associated with increased femur BMD compared to non-MASLD patients, especially in women and overweight individuals. Interestingly, increased risk of OP\/osteoporotic fractures and decreased BTMs were significantly associated with MASLD. This may suggest that BMD underestimates the risk of OP\/osteoporotic fractures in MASLD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1717852","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:43:55Z","timestamp":1768196635000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of metabolic dysfunction-associated steatotic liver disease with bone health in adults: a systematic review and meta-analysis of observational studies"],"prefix":"10.3389","volume":"16","author":[{"given":"Xingzhi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"149466","DOI":"10.1016\/j.gene.2025.149466","article-title":"Cell and gene therapeutic approaches in non-alcoholic fatty liver disease","volume":"956","author":"Poudineh","year":"2025","journal-title":"Gene"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1186\/s12889-024-19047-y","article-title":"The burden of non-alcoholic fatty liver disease among working-age people in the Western Pacific Region, 1990-2019: an age-period-cohort analysis of the Global Burden of Disease study","volume":"24","author":"Lv","year":"2024","journal-title":"BMC Public Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): A state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e86963","DOI":"10.7759\/cureus.86963","article-title":"Pathological evolution and internal medicine management of nonalcoholic fatty liver disease (NAFLD) in the era of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"17","author":"Hashim","year":"2025","journal-title":"Cureus"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.20.00989","article-title":"Oxidative stress and osteoporosis","volume":"103","author":"Kimball","year":"2021","journal-title":"J Bone Joint Surg Am"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6301433","DOI":"10.1155\/2021\/6301433","article-title":"Role of exosomal microRNAs and their crosstalk with oxidative stress in the pathogenesis of osteoporosis","volume":"2021","author":"Lu","year":"2021","journal-title":"Oxid Med Cell longev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41413-022-00190-4","article-title":"Mechanical regulation of bone remodeling","volume":"10","author":"Wang","year":"2022","journal-title":"Bone Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41413-018-0019-6","article-title":"Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts","volume":"6","author":"Han","year":"2018","journal-title":"Bone Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2011.602","article-title":"International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis","volume":"49","author":"Vasikaran","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0699","article-title":"Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease: a cohort study","volume":"182","author":"Shen","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0528-3","article-title":"Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults","volume":"39","author":"Lee","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0182202","DOI":"10.1371\/journal.pone.0182202","article-title":"Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease","volume":"12","author":"Kim","year":"2017","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3010","article-title":"Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese","volume":"97","author":"Li","year":"2012","journal-title":"J Clin Endocr Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00408","article-title":"Association of nonalcoholic fatty liver disease with osteoporotic fractures: A cross-sectional retrospective study of chinese individuals","volume":"9","author":"Wang","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-016-0229-0","article-title":"Obesity, type 2 diabetes and bone in adults","volume":"100","author":"Walsh","year":"2017","journal-title":"Calcified Tissue Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evid Based Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2314769","DOI":"10.1155\/2018\/2314769","article-title":"The combined effect of nonalcoholic fatty liver disease and metabolic syndrome on osteoporosis in postmenopausal females in eastern China","volume":"2018","author":"Chen","year":"2018","journal-title":"Int J Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e12835","DOI":"10.1097\/MD.0000000000012835","article-title":"Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease: A population-based retrospective cohort study","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3961\/jpmph.20.089","article-title":"Relationship between non-alcoholic fatty liver disease and decreased bone mineral density: A retrospective cohort study in korea","volume":"53","author":"Sung","year":"2020","journal-title":"J Prev Med Public Health"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.825448","article-title":"Prevalence and trends in low bone density, osteopenia and osteoporosis in U.S. Adults with non-alcoholic fatty liver disease, 2005-2014","volume":"12","author":"Zhai","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab262","article-title":"NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population","volume":"106","author":"Ciardullo","year":"2021","journal-title":"J Clin Endocr Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1055\/a-1482-9236","article-title":"Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of osteoporosis and bone fractures","volume":"60","author":"Loosen","year":"2022","journal-title":"Z Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.891382","article-title":"Association of metabolic dysfunction-associated fatty liver disease and liver stiffness with bone mineral density in american adults","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/joim.13497","article-title":"Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study","volume":"292","author":"Wester","year":"2022","journal-title":"J Intern Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1278505","article-title":"Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia\/osteoporosis in T2DM patients","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/s13018-023-04168-8","article-title":"Relationship between nonalcoholic fatty liver disease and bone mineral density in elderly Chinese","volume":"18","author":"Zhang","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1156996","article-title":"Association between the fatty liver index and the risk of fracture among individuals over the age of 50 years: a nationwide population-based study","volume":"14","author":"Chung","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03934-w","article-title":"Bone mass, microarchitecture and turnover among young Indian women with non-alcoholic fatty liver disease","volume":"86","author":"Goyal","year":"2024","journal-title":"Endocrine"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1530\/EC-24-0089","article-title":"Optimal body mass index for protecting middle-aged and elderly patients with fatty liver from future fractures","volume":"13","author":"Yeh","year":"2024","journal-title":"Endocr Connect"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9639-6","article-title":"Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women","volume":"42","author":"Moon","year":"2012","journal-title":"Endocrine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"396545","DOI":"10.1155\/2013\/396545","article-title":"Low bone mineral density in chinese adults with nonalcoholic Fatty liver disease","volume":"2013","author":"Cui","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12967-016-0766-3","article-title":"The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women","volume":"14","author":"Xia","year":"2016","journal-title":"J Transl Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/13697137.2018.1481380","article-title":"Association between nonalcoholic fatty liver disease and bone mineral density in postmenopausal women","volume":"21","author":"Lee","year":"2018","journal-title":"Climacteric"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0197900","DOI":"10.1371\/journal.pone.0197900","article-title":"Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults","volume":"13","author":"Umehara","year":"2018","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10254-y","article-title":"Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease","volume":"15","author":"Yoon","year":"2021","journal-title":"Hepatol Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.857110","article-title":"Relationship between non-alcoholic fatty liver disease and degree of hepatic steatosis and bone mineral density","volume":"13","author":"Xie","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S364804","article-title":"Risk factors for nonalcoholic fatty liver disease in postmenopausal women with type 2 diabetes mellitus and the correlation with bone mineral density at different locations","volume":"15","author":"Du","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-023-06687-w","article-title":"Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017-2018","volume":"34","author":"Liu","year":"2023","journal-title":"Osteoporosis Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e10714","DOI":"10.1002\/jbm4.10714","article-title":"Are nonalcoholic fatty liver disease and bone mineral density associated? - A Cross-Sectional Study Using Liver Biopsy and Dual-Energy X-Ray Absorptiometry","volume":"7","author":"Hansen","year":"2023","journal-title":"JBMR Plus"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03724-4","article-title":"The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD","volume":"85","author":"Pan","year":"2024","journal-title":"Endocrine"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms141019782","article-title":"Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in adult males, South China","volume":"14","author":"Liu","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2015.81","article-title":"Inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levels","volume":"36","author":"Luo","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000535","article-title":"Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men","volume":"28","author":"Yang","year":"2016","journal-title":"Eur J gastroen hepat"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201804_14799","article-title":"Analysis of the correlation between non-alcoholic fatty liver disease and bone metabolism indicators in healthy middle-aged men","volume":"22","author":"Deng","year":"2018","journal-title":"Eur Rev Med pharmaco"},{"key":"B49","doi-asserted-by":"publisher","first-page":"101397","DOI":"10.1016\/j.diabet.2022.101397","article-title":"Low levels of osteocalcin, but not CTX or P1NP, are associated with nonalcoholic hepatic steatosis and steatohepatitis","volume":"49","author":"Fang","year":"2023","journal-title":"Diabetes Metab"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2022.07.003","article-title":"Bone metabolism discrepancy in type 2 diabetes mellitus patients with and without non-alcoholic fatty liver disease","volume":"25","author":"Wang","year":"2022","journal-title":"J Clin densitom"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01861-z","article-title":"Chinese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease have lower serum osteocalcin levels compared to individuals with type 2 diabetes mellitus and no liver disease: a single-center cross-sectional study","volume":"45","author":"Fu","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0174","article-title":"Increased risk of non-alcoholic fatty liver disease fibrosis is closely associated with osteoporosis in women but not in men with type 2 diabetes","volume":"11","author":"Yu","year":"2022","journal-title":"Endocr Connect"},{"key":"B53","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/00325481.2024.2333718","article-title":"Association between serum ferritin and bone turnover marker levels in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease","volume":"136","author":"Chen","year":"2024","journal-title":"Postgrad Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15087","article-title":"Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density","volume":"49","author":"Mantovani","year":"2019","journal-title":"Aliment Pharm therap"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-016-0807-2","article-title":"Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis","volume":"35","author":"Upala","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4862","article-title":"Nonalcoholic fatty liver disease is associated with decreased bone mineral density in adults: A systematic review and meta-analysis","volume":"38","author":"Su","year":"2023","journal-title":"J Bone miner Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/64.3.345","article-title":"A multicenter study of the influence of fat and lean mass on bone mineral content: evidence for differences in their relative influence at major fracture sites. Early Postmenopausal Intervention Cohort (EPIC) Study Group","volume":"64","author":"Hla","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1520408112","article-title":"The bone-sparing effects of estrogen and WNT16 are independent of each other","volume":"112","author":"Mov\u00e9rare-Skrtic","year":"2015","journal-title":"P Natl Acad Sci USA"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(93)90241-F","article-title":"The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women","volume":"42","author":"Haffner","year":"1993","journal-title":"Metabolism"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s002239900557","article-title":"Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women","volume":"63","author":"Goulding","year":"1998","journal-title":"Calcified Tissue Int"},{"key":"B61","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1530\/JOE-16-0405","article-title":"Hormonal alterations in PCOS and its influence on bone metabolism","volume":"232","author":"Krishnan","year":"2017","journal-title":"J Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-005-1863-y","article-title":"Body mass index as a predictor of fracture risk: a meta-analysis","volume":"16","author":"De Laet","year":"2005","journal-title":"Osteoporosis Int"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(95)00031-T","article-title":"Aromatase in bone cell: association with osteoporosis in postmenopausal women","volume":"53","author":"Nawata","year":"1995","journal-title":"J Steroid Biochem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-1-174","article-title":"Effects of aging and obesity on aromatase activity of human adipose cells","volume":"60","author":"Cleland","year":"1985","journal-title":"J Clin Endocr Metab"},{"key":"B65","doi-asserted-by":"publisher","first-page":"108168","DOI":"10.1016\/j.pharmthera.2022.108168","article-title":"Advances in pathogenesis and therapeutic strategies for osteoporosis","volume":"237","author":"Song","year":"2022","journal-title":"Pharmacol therapeut"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac031","article-title":"Bone turnover markers: basic biology to clinical applications","volume":"44","author":"Schini","year":"2023","journal-title":"Endocr Rev"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2018.05.003","article-title":"Bone turnover: Biology and assessment tools","volume":"32","author":"Szulc","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-04819-1","article-title":"Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE","volume":"30","author":"Eastell","year":"2019","journal-title":"Osteoporos Int"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512063","article-title":"Equol and resveratrol improve bone turnover biomarkers in postmenopausal women: A clinical trial","volume":"24","author":"Corbi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25930","article-title":"Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus","volume":"56","author":"Barchetta","year":"2012","journal-title":"Hepatology"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-015-0687-x","article-title":"Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease","volume":"34","author":"Polyzos","year":"2016","journal-title":"J Bone miner Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-024-10660-y","article-title":"MAFLD as part of systemic metabolic dysregulation","volume":"18","author":"Zhao","year":"2024","journal-title":"Hepatol Int"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14641","article-title":"Bone microarchitecture, bone mineral density and bone turnover in association with glycemia and insulin action in women with prior gestational diabetes","volume":"96","author":"Kubihal","year":"2022","journal-title":"Clin Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1530\/EJE-16-0652","article-title":"MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis","volume":"176","author":"Hygum","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2676-7","article-title":"Biochemical markers of bone turnover in diabetes patients--a meta-analysis, and a methodological study on the effects of glucose on bone markers","volume":"25","author":"Starup-Linde","year":"2014","journal-title":"Osteoporosis Int"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-014-0054-x","article-title":"Association between metabolic syndrome and osteoporotic fracture in middle-aged and elderly Chinese peoples","volume":"70","author":"Wang","year":"2014","journal-title":"Cell Biochem Biophys"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06459-y","article-title":"Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"33","author":"Pan","year":"2022","journal-title":"Osteoporos Int"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052604","article-title":"An overview of the molecular mechanisms contributing to musculoskeletal disorders in chronic liver disease: osteoporosis, sarcopenia, and osteoporotic sarcopenia","volume":"22","author":"Yang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn501113-20210208-00078","article-title":"Liver cirrhosis and secondary osteoporosis","volume":"29","author":"Yang","year":"2021","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S170533","article-title":"Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis","volume":"13","author":"Filip","year":"2018","journal-title":"Clin Interv Aging"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2793","article-title":"Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells","volume":"18","author":"Xian","year":"2012","journal-title":"Nat Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03351-5","article-title":"Long-term outcomes in lean and non-lean NAFLD patients: a systematic review and meta-analysis","volume":"85","author":"Huang","year":"2024","journal-title":"Endocrine"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17424","article-title":"Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities","volume":"57","author":"Wijarnpreecha","year":"2023","journal-title":"Aliment Pharm therap"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.17015","article-title":"Increased mortality among lean versus non-lean adults with MASLD: A multicenter study","volume":"40","author":"Ghani","year":"2025","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1717852\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:43:59Z","timestamp":1768196639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1717852\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":85,"alternative-id":["10.3389\/fendo.2025.1717852"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1717852","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1717852"}}